- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00408499 | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | University of California, DavisOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | completed | Phase 2 | 12 | St. Jude Children's Research HospitalOTHER |
| 1 |
| Apr 26, 2017 |
| clinicaltrials |
| NCT00952848 | Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy | completed | Phase 2 | 18 | Virginia Commonwealth UniversityOTHER | 0 | Mar 29, 2017 | clinicaltrials |
| NCT00311597 | Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 48 | Wake Forest University Health SciencesOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00416624 | Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy | completed | Phase 2 | 239 | Mayo ClinicOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00003657 | High-dose ICE With Amifostine | completed | Phase 2 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT00064272 | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer(IRB 2003-551) | completed | Phase 2 | 180 | University of Michigan Rogel Cancer CenterOTHER | 2 | Oct 21, 2016 | clinicaltrials |
| NCT00003130 | Paclitaxel in Treating Women With Recurrent Solid Tumors | completed | Phase 2 | 32 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT01008904 | Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer | completed | Phase 2 | 31 | Virginia Commonwealth UniversityOTHER | 0 | Jun 21, 2016 | clinicaltrials |
| NCT00888134 | Selumetinib in Cancers With BRAF Mutations | completed | Phase 2 | 28 | National Cancer Institute (NCI)NIH | 1 | Jan 15, 2016 | clinicaltrials |
| NCT00082290 | Massage Therapy in Treating Patients With Cancer Pain | completed | Phase 2 | 92 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00053846 | Buspirone in Reducing Shortness of Breath in Patients With Cancer | completed | Phase 2 / Phase 3 | 432 | University of RochesterOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00003817 | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | completed | Phase 2 | 700 | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00521144 | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
| NCT00706290 | Brief CBT for Anxiety and Advanced Cancer | completed | Phase 2 | 49 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT00607880 | Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy | completed | Phase 2 | 100 | Mayo ClinicOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00477607 | Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin | completed | Phase 2 / Phase 3 | 39 | US Department of Veterans AffairsFED | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00004979 | Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00020618 | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain | completed | Phase 2 | — | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003878 | Carmustine Implants in Treating Patients With Brain Metastases | completed | Phase 2 | — | New Approaches to Brain Tumor Therapy ConsortiumOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00021164 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00059878 | Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00060255 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 451 | Roswell Park Cancer InstituteOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00003406 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | completed | Phase 1 / Phase 2 | 30 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00091052 | Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Sirius MedicineINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00003173 | High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | completed | Phase 2 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00255749 | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | completed | Phase 2 | 89 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00086723 | In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00004914 | Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004912 | Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00541138 | Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors | completed | Phase 2 | 50 | City of Hope Medical CenterOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT00559195 | Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors | completed | Phase 2 | 40 | Centre Hospital Regional Universitaire de LimogesOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00002504 | Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00002505 | Tumor Cell Vaccine in Treating Patients With Advanced Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00002733 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | 30 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00004105 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00004030 | VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin | completed | Phase 1 / Phase 2 | 45 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00003894 | Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant | completed | Phase 2 | 36 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
Data updated 22 days agoSource updated May 8, 2017source: clinicaltrials